Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Novel Pure [apha]V[beta]3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Rece

Journal Article · · ACS Pharmacol. Transl. Sci.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1836708
Journal Information:
ACS Pharmacol. Transl. Sci., Vol. 2, Issue (6)
Country of Publication:
United States
Language:
ENGLISH

References (100)

The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend journal October 2008
Integrin αIIbβ3: From Discovery to Efficacious Therapeutic Target journal April 2013
Osteoclasts, integrins, and osteoporosis journal October 2000
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance journal April 2015
The role of β3-integrins in tumor angiogenesis: context is everything journal October 2011
Osteoporosis and Integrins journal April 2005
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. journal May 1997
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease journal January 2014
Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factor journal January 2000
Small-molecule cyclic αVβ3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion journal August 2007
Tumor Angiogenesis: Putting a Value on Plastic GEMMs journal January 2014
Integrin αvβ3 Signaling in Tumor-Induced Bone Disease journal July 2017
Herpes Simplex Virus Type 2 Glycoprotein H Interacts with Integrin  v 3 To Facilitate Viral Entry and Calcium Signaling in Human Genital Tract Epithelial Cells journal June 2014
Andes Virus Recognition of Human and Syrian Hamster β 3 Integrins Is Determined by an L33P Substitution in the PSI Domain journal January 2010
 3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure journal June 1998
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease journal June 2017
Blocking α V β 3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats journal January 2014
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma journal October 2013
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs journal November 2013
Engagement of αvβ3 Integrin Regulates Proliferation and Apoptosis of Hepatic Stellate Cells journal June 2004
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro journal May 2007
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model journal March 2016
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging journal December 2015
In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling journal July 2013
The role of vitronectin receptor (αvβ3) and tissue factor in the pathogenesis of transplant coronary vasculopathy journal March 2002
Myocardial Ischemic Injury After Heart Transplantation Is Associated With Upregulation of Vitronectin Receptor (α v β 3 ), Activation of the Matrix Metalloproteinase Induction System, and Subsequent Development of Coronary Vasculopathy journal April 2002
β 3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells journal August 2009
Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis journal February 2016
Increased Activation of Latent TGF-β1 by αVβ3 in Human Crohnʼs Disease and Fibrosis in TNBS Colitis Can Be Prevented by Cilengitide journal January 2013
Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells journal December 2015
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells journal January 2015
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice journal April 2019
Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors journal September 2017
Soluble Urokinase Receptor and Chronic Kidney Disease journal November 2015
SuPAR, an emerging biomarker in kidney and inflammatory diseases journal September 2018
Alpha-v Integrins as Therapeutic Targets in Oncology journal January 2007
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma journal February 2015
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome journal February 2016
Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women journal April 2005
Evaluation of the safety, pharmacokinetics and treatment effects of an α ν β 3 integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases journal March 2010
Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. journal September 1987
Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. journal April 1990
Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. journal September 1991
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics journal September 2004
Integrin Priming Dynamics: Mechanisms of Integrin Antagonist-Promoted αIIbβ3:PAC-1 Molecular Recognition journal August 2009
β-Subunit Binding Is Sufficient for Ligands to Open the Integrin α IIb β 3 Headpiece journal December 2015
Structure-Guided Design of a High-Affinity Platelet Integrin  IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS journal March 2012
α IIb β 3 priming and clustering by orally active and intravenous integrin antagonists journal March 2007
Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa) journal May 1991
Application of high-throughput screening to identify a novel αIIb-specific small- molecule inhibitor of αIIbβ3-mediated platelet interaction with fibrinogen journal February 2008
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening journal December 2010
Oral Glycoprotein IIb/IIIa Inhibitors: Why Don??t They Work? journal January 2001
Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes journal November 2000
Oral GPIIb / IIIa Antagonists: What Went Wrong? journal May 2004
Differential Expression of a Ligand Induced Binding Site (LIBS) by GPIIb-IIIa Ligand Recognition Peptides and Parenteral Antagonists journal January 2000
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin journal June 2012
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand journal March 2002
Topography of Ligand-induced Binding Sites, Including a Novel Cation-sensitive Epitope (AP5) at the Amino Terminus, of the Human Integrin Subunit journal May 1995
A Naturally Occurring Point Mutation in the β3 Integrin MIDAS-like Domain Affects Differently αvβ3 and αIIbβ3 Receptor Function journal January 2001
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors journal March 2009
Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling journal September 2002
Superactivation of integrin (α)v(β)3 by low antagonist concentrations journal April 2001
Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells journal February 1994
Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis journal July 2009
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin journal March 2014
Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin journal July 2008
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to α v β 3 without Promoting Integrin Allosteric Activation journal June 2018
Non-Peptide Fibrinogen Receptor Antagonists. 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor Antagonist journal August 1995
Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis journal April 2015
Nonpeptide α v β 3 Antagonists. Part 11:  Discovery and Preclinical Evaluation of Potent α v β 3 Antagonists for the Prevention and Treatment of Osteoporosis journal August 2004
Structure and mechanics of integrin-based cell adhesion journal October 2007
Use of the mouse aortic ring assay to study angiogenesis journal December 2011
Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice journal January 2014
αvβ3 Integrin and tumour blood vessels—learning from the past to shape the future journal October 2016
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 journal September 2001
Mechanisms and Consequences of Affinity Modulation of Integrin αVβ3 Detected with a Novel Patch-engineered Monovalent Ligand journal July 1999
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis journal July 2011
Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma journal April 2018
Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel journal January 1991
Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses? journal September 2017
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model journal September 2017
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. journal April 1991
Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts journal February 2000
Dissection of platelet and myeloid cell defects by conditional targeting of the β3‐integrin subunit journal November 2009
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis journal December 2014
Critical Role of β3 Integrin in Experimental Postmenopausal Osteoporosis journal July 2005
Upregulation of osteoclast α2β1 integrin compensates for lack of αvβ3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia: Osteoclast Function in Glanzmann Thrombasthenia journal September 2003
PLATELET GLYCOPROTEIN IIb-IIIa-LIKE PROTEINS MEDIATE ENDOTHELIAL CELL ATTACHMENT TO ADHESIVE MATRIX PROTEINS AND ARE UP-REGULATED BY PHORBOL ESTERS conference August 2018
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment journal April 1993
Identification and Characterization of the New Osteoclast Progenitor with Macrophage Phenotypes Being Able to Differentiate into Mature Osteoclasts journal August 2000
Fiji: an open-source platform for biological-image analysis journal June 2012
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Phaser crystallographic software journal July 2007
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
A systematic survey of conformational states in β1 and β4 integrins using negative-stain electron microscopy journal April 2018
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line journal October 2002
Negative staining and image classification — powerful tools in modern electron microscopy journal January 2004
RELION: Implementation of a Bayesian approach to cryo-EM structure determination journal December 2012
EMAN2: An extensible image processing suite for electron microscopy journal January 2007
SPIDER and WEB: Processing and Visualization of Images in 3D Electron Microscopy and Related Fields journal January 1996